Surveillance of patients with Barrett’s esophagus after complete eradication of intestinal metaplasia
- José Miguel Esteban López-Jamar 1
- Ravishankar Asokkumar 1
- Jacobo Ortiz Fernández Sordo 2
- Rehan Haidry 3
- 1 Hospital Clínico San Carlos. Madrid, Spain
- 2 Nottingham University Hospitals NHS Trust and University of Nottingham. Nottingham, United Kingdom
- 3 University College Hospital. London, United Kingdom
ISSN: 2340-416, 1130-0108
Año de publicación: 2020
Volumen: 112
Número: 11
Páginas: 864-868
Tipo: Artículo
Otras publicaciones en: Revista Española de Enfermedades Digestivas
Objetivos de desarrollo sostenible
Resumen
A 55-year-old Caucasian male with a long history of smoking and reflux disease underwent endoscopic evaluation for dyspepsia. During upper endoscopy, a 4 cm long Barrett’s segment with an 8 mm nodular lesion was detected. The lesion was removed en-bloc by endoscopic mucosal resection and biopsies were taken from the adjacent columnar epithelium. The histology of the lesion revealed high-grade dysplasia with clear resection margins and no lymphovascular invasion. The remaining biopsies did not show any dysplastic changes. He subsequently underwent three sequential sessions of radiofrequency ablation (RFA) to eradicate the remaining Barrett’s epithelium. When this type of case presents to the clinic for follow-up, what do you do next?